A June 7 article published by The Economist reviews China’s recently passed rules on Human Genetic Resources (HGR), passed on June 1 by China’s Ministry of Science and Technology (the “MOST”). The article featured insights from life sciences partner Katherine Wang (Shanghai) .
Despite concerns that certain new restrictions impose a heavy burden on multinational pharmaceutical firms, hamper data sharing and clinical trials, Katherine balances the piece by highlighting that “The updates do loosen restrictions in some areas.” Katherine outlines that “the simplification of review and approval procedures [are] … a positive development.”
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.